ArriVent BioPharma, Inc. - Common Stock (AVBP)

CUSIP: 04272N102

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock
Total 13F shares
40,108,234
Total 13F value
$810,286,038
Holder snapshot 6 visible 7 signals
Share change
+929,182
Put/Call ratio
0%
SEC-reported price per share
$20.12
Number of holders
122
Value change
+$21,067,734
Number of buys
69
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
46,795,294

Security key

04272N102

Report period

Q4 2025

Institutions

122

Top holders

10

AVBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 ArriVent BioPharma, Inc. SEC filings ArriVent BioPharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INFINITUM ASSET MANAGEMEN...
Disclosed value leader
HILLHOUSE INVESTMENT MANA...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: INFINITUM ASSET MANAGEMENT, LLC Showing 1-6 of 15 holder rows.

Quick read

INFINITUM ASSET MANAGEMENT, LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INFINITUM ASSET MANAGEMENT, LLC's linked filing trail.
Comparable ownership Top 5
INFINITUM ASSET MANAGEMENT, LLC 9.9%
SUVRETTA CAPITAL MANAGEMENT, LLC 9.9%
HILLHOUSE INVESTMENT MANAGEMENT, ... 9.5%
ORBIMED ADVISORS LLC 7.5%
HBM Healthcare Investments (Cayma... 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INFINITUM ASSET MANAGEMENT, LLC
13D/G 13F
Company
13D/G 13F
9.9%
$90,602,588
4,123,923 shares
 +$15,488,850 31 Dec 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 13F
Company
13D/G 13F
9.9%
$75,183,720
3,412,788 shares
 $0 30 Jun 2025
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
3/4/5 13D/G
10%+ Owner
3/4/5 13D/G
9.5%
from 13D/G
$91,823,464
3,929,117 shares
 -$12,983,320 10 Dec 2025
ORBIMED ADVISORS LLC
13D/G 3/4/5 13F
Director, 10%+ Owner · Company
13D/G 3/4/5 13F
7.5%
$66,692,036
3,027,328 shares
 $0 11 Aug 2025
HBM Healthcare Investments (Cayman) Ltd.
13D/G
13D/G
5.4%
$40,491,643
2,195,014 shares
 $0 08 Oct 2025
Octagon Capital Advisors LP
13D/G 13F
Company
13D/G 13F
4.9%
$36,365,946
1,971,054 shares
 $0 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
122
Shares
40,108,234
Rows available
122
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
104
Q4 2025 holders
122
Holder diff
18
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .